Stoneridge Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Stoneridge de 154.2% y 5.4% respectivamente, mientras que el BPA crecerá en un 153.3% al año.

Información clave

154.2%

Tasa de crecimiento de los beneficios

153.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Auto Components	18.9%
Tasa de crecimiento de los ingresos	5.4%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	02 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Need To Know: Analysts Are Much More Bullish On Stoneridge, Inc. (NYSE:SRI) Revenues

Mar 09

Stoneridge (NYSE:SRI) Takes On Some Risk With Its Use Of Debt

Jan 13

The Returns On Capital At Stoneridge (NYSE:SRI) Don't Inspire Confidence

Nov 01

Does Stoneridge (NYSE:SRI) Have A Healthy Balance Sheet?

Aug 06

Stoneridge, Inc.'s (NYSE:SRI) CEO Compensation Looks Acceptable To Us And Here's Why

May 05

Stoneridge, Inc. 2021 Q1 - Results - Earnings Call Presentation

Apr 30

Does Stoneridge (NYSE:SRI) Have A Healthy Balance Sheet?

Apr 13

What Do The Returns On Capital At Stoneridge (NYSE:SRI) Tell Us?

Mar 15

Introducing Stoneridge (NYSE:SRI), The Stock That Zoomed 157% In The Last Five Years

Feb 16

Stoneridge (NYSE:SRI) Is Carrying A Fair Bit Of Debt

Jan 12

Have Insiders Been Selling Stoneridge, Inc. (NYSE:SRI) Shares?

Dec 08

Stoneridge, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 06

Stoneridge EPS beats by $0.33, beats on revenue

Oct 28

Previsiones de crecimiento de beneficios e ingresos

NYSE:SRI - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	1,067	19	N/A	N/A	2
12/31/2024	995	3	N/A	N/A	2
3/31/2024	974	-4	-11	23	N/A
12/31/2023	976	-5	-34	5	N/A
9/30/2023	977	-8	-12	25	N/A
6/30/2023	966	-9	-15	20	N/A
3/31/2023	920	-14	-17	17	N/A
12/31/2022	900	-14	-25	7	N/A
9/30/2022	872	-20	-69	-41	N/A
6/30/2022	827	-32	-59	-31	N/A
3/31/2022	798	-4	-66	-39	N/A
12/31/2021	770	3	-63	-36	N/A
9/30/2021	757	13	-30	0	N/A
6/30/2021	751	30	-17	13	N/A
3/31/2021	659	-11	-15	18	N/A
12/31/2020	648	-8	-4	29	N/A
9/30/2020	649	-7	-20	13	N/A
6/30/2020	676	-7	-28	11	N/A
3/31/2020	799	54	-14	24	N/A
12/31/2019	834	60	-15	25	N/A
9/30/2019	855	68	17	54	N/A
6/30/2019	860	75	29	59	N/A
3/31/2019	859	50	38	65	N/A
12/31/2018	866	54	52	81	N/A
9/30/2018	863	61	45	75	N/A
6/30/2018	858	55	47	81	N/A
3/31/2018	846	49	43	79	N/A
12/31/2017	824	45	N/A	79	N/A
9/30/2017	790	75	N/A	79	N/A
6/30/2017	760	77	N/A	75	N/A
3/31/2017	738	79	N/A	74	N/A
12/31/2016	696	77	N/A	65	N/A
9/30/2016	678	35	N/A	75	N/A
6/30/2016	666	32	N/A	71	N/A
3/31/2016	645	28	N/A	60	N/A
12/31/2015	645	23	N/A	55	N/A
9/30/2015	657	-8	N/A	38	N/A
6/30/2015	665	-7	N/A	29	N/A
3/31/2015	662	-36	N/A	32	N/A
12/31/2014	661	-38	N/A	20	N/A
9/30/2014	663	-9	N/A	20	N/A
6/30/2014	654	-10	N/A	33	N/A
3/31/2014	662	17	N/A	28	N/A
12/31/2013	659	19	N/A	44	N/A
9/30/2013	713	18	N/A	58	N/A
6/30/2013	771	12	N/A	63	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que SRI sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.4%).

Beneficios vs. Mercado: Se prevé que SRI sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que SRI sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (4.5% al año) de SRI crezcan más despacio que el mercado de US (8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.5% al año) de SRI crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SRI se prevé que sea elevada dentro de 3 años.

Stoneridge Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Stoneridge, Inc. Provides Earnings Guidance for the Full Year 2024 and the Year 2028

Stoneridge, Inc. Provides Revenue Guidance for the Year 2024

Price target decreased by 7.3% to US$25.25

Price target decreased by 7.3% to US$25.25

Price target increased to US$27.75

Stoneridge, Inc. Updates Earnings Guidance for the Fourth Quarter of 2022

Recent updates

New major risk - Revenue and earnings growth

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

The Returns On Capital At Stoneridge (NYSE:SRI) Don't Inspire Confidence

Stoneridge, Inc., Annual General Meeting, May 14, 2024

Stoneridge, Inc. Appoints Troy Cooprider as Chief Technology Officer

Stoneridge, Inc.'s (NYSE:SRI) Shareholders Might Be Looking For Exit

New major risk - Revenue and earnings growth

Stoneridge, Inc. Provides Earnings Guidance for the Full Year 2024 and the Year 2028

Stoneridge's MirrorEye® Camera Monitor System Receives FMCSA Exemption Renewal

Stoneridge's MirrorEye® Camera Monitor System Receives FMCSA Exemption Renewal

These 4 Measures Indicate That Stoneridge (NYSE:SRI) Is Using Debt Extensively

Third quarter 2023 earnings: EPS exceeds analyst expectations

Stoneridge, Inc. Provides Revenue Guidance for the Year 2024

Returns On Capital Signal Difficult Times Ahead For Stoneridge (NYSE:SRI)

Here's Why Stoneridge (NYSE:SRI) Has A Meaningful Debt Burden

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 7.3% to US$25.25

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased by 7.3% to US$25.25

CTO & Chief Strategy Officer exercised options and sold US$174k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Stoneridge (NYSE:SRI) A Risky Investment?

Stoneridge, Inc. Announces Resignation of Jeffrey P. Draime from Board of Directors

Stoneridge, Inc. Announces Chief Executive Officer Changes

Stoneridge appoints former Aptiv executive Jim Zizelman as president, CEO

Insufficient new directors

Price target increased to US$27.75

Stoneridge, Inc. Updates Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Would Stoneridge (NYSE:SRI) Be Better Off With Less Debt?

Independent Director recently bought US$76k worth of stock

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Stoneridge, Inc. Revises Earnings Guidance for the Full Year 2022

Price target decreased to US$24.00

Stoneridge, Inc. Announces Management Changes

Stoneridge, Inc.(NYSE:SRI) dropped from Russell 2000 Value-Defensive Index

Stoneridge (NYSE:SRI) Is Making Moderate Use Of Debt

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to US$25.00

Stoneridge, Inc. Provides Earnings Guidance for the Year 2022

Insufficient new directors

Stoneridge, Inc., Annual General Meeting, May 17, 2022

Need To Know: Analysts Are Much More Bullish On Stoneridge, Inc. (NYSE:SRI) Revenues

CEO, President & Director recently bought US$243k worth of stock

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Stoneridge (NYSE:SRI) Takes On Some Risk With Its Use Of Debt

Minda Corporation Limited (NSEI:MINDACORP) completed the acquisition of remaining 49% stake in Minda Stoneridge Instruments Ltd. from Stoneridge, Inc. (NYSE:SRI)

Investor sentiment improved over the past week

The Returns On Capital At Stoneridge (NYSE:SRI) Don't Inspire Confidence

Third quarter 2021 earnings released: US$0.38 loss per share (vs US$0.25 profit in 3Q 2020)

Price target decreased to US$36.00

Executive VP, CFO & Treasurer Robert Krakowiak has left the company

CTO & President of Electronics Division recently sold US$273k worth of stock

Chief Legal Officer & Secretary Thomas Dono has left the company

Does Stoneridge (NYSE:SRI) Have A Healthy Balance Sheet?

An unknown buyer acquired Canton, Massachusetts facility from Stoneridge, Inc. (NYSE: SRI).

Stoneridge, Inc. Provides Earnings Guidance for 2021

Second quarter 2021 earnings released: EPS US$0.73 (vs US$0.81 loss in 2Q 2020)

Price target increased to US$45.00

Stoneridge, Inc.'s (NYSE:SRI) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased to US$45.00

First quarter 2021 earnings released: EPS US$0.005 (vs US$0.13 in 1Q 2020)

Stoneridge, Inc. 2021 Q1 - Results - Earnings Call Presentation

Stoneridge, Inc. Maintains Revenue Guidance for the Year 2021

Does Stoneridge (NYSE:SRI) Have A Healthy Balance Sheet?

What Do The Returns On Capital At Stoneridge (NYSE:SRI) Tell Us?

CTO & President of Electronics Division exercised options and sold US$131k worth of stock

Montgomery Transport Reinforces Company Commitment to Safety Innovation with Fleet-Wide Adoption of Stoneridge MirrorEye® Camera Monitor System